Lineage Cell Therapeutics, Inc.

Industry

  • Medical Devices
    • Biomaterials
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Technologies
      • Bioinformatics
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery

Other Names/Subsidiaries

  • Asterias Biotherapeutics, Inc.
  • BioTime Acquisition Corp.
  • BioTime, Inc.
  • Cell Cure Neurosciences Ltd.
  • Embryome Sciences
  • ES Cell International Pte Ltd
  • LifeMap Sciences, Inc.
  • OncoCyte Corporation
  • ReCyte Therapeutics
See more in Biomedtracker

Latest on Lineage Cell Therapeutics, Inc.

Scrip

Apellis Set For Blockbuster Success With Syfovre, The First Approved Geographic Atrophy Drug

 
• By Andrew McConaghie

Apellis Pharmaceuticals has achieved a milestone with the US approval of Syfovre, the first treatment for geographic atrophy, and looks set to lead a new multi-billion-dollar market for the ophthalmi

Scrip

Deal Watch: Moderna, ElevateBio Subsidiary To Combine mRNA With Gene Editing

 
• By Joseph Haas, Dexter Jie Yan, and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Busy Moderna Inks Gene-Editing Pact Wit

Scrip

Up Next For Roche In Ophthalmology: Nine Clinical-Stage Programs

 
• By Jessica Merrill

With Roche Holding AG 's new wet age-related macular degeneration (AMD) and diabetic eye disease drug Vabysmo (faricimab) off to an impressive early commercial launch, the company showcased the eye d

Scrip

Deal Watch: Roche, Pfizer, GSK Close Out 2021 With Licensing Transactions

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Roche/Genentech Bring In Cell Therapy C